Guard and Arsonist: Why a Gut Protein's Double Role Matters for Targeted IBD Drugs
A study by the National Institute of Immunology, New Delhi, published in PNAS and reported by The Hindu on 19 October 2026, shows that RelB plays opposite roles in gut immunity depending on location - a finding relevant to designing safer, targeted therapies for inflammatory bowel disease. Researchers at the National Institute of Immunology (NII), New Delhi, discovered that the RelB protein plays a paradoxical, dual role in…